TriSalus Life Sciences, Inc. (TLSIW) Free cash flow 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.9MFY2025 · since FY2022: -$33.0M → -$18.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.9M | +54.0% |
| FY2024 | -$41.2M | +19.5% |
| FY2023 | -$51.2M | -55.2% |
| FY2022 | -$33.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →